Samples were electrophoresed (80 V, 0.5 h, then 120 V, 1H) and transferred to polyvinylidene fluoride membranes (280 mA, 1 kda/min)
Zhu B, Ni Y, Gong Y, Kang X, Guo H, Liu X, Li J, Wang L
While back pain is not among the frequently reported adverse events in major clinical trials of GLP-1 receptor agonists, the experience of losing weight quickly can create mechanical stress on the spine and supporting structuresa phenomenon separate from the medication itself
No, this procedure is not FDA-Approved for this use
Access this article Similar content being viewed by others References Sjstrm L, Peltonen M, Jacobson P, et al
Post-hoc analyses of the SURMOUNT clinical trial program specifically evaluated treatment response by reproductive stage